Lessons Learned from the HVAD Post-Approval Study Registry: Implications for Investigating Future Ventricular Assist Device Technology

IF 9.9 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Cardiac Failure Pub Date : 2026-10-01 Epub Date: 2026-03-13 DOI:10.1016/j.cardfail.2026.01.022

JENNIFER A. COWGER MD, MS, IGOR D. GREGORIC MD, MBA, LIVIU KLEIN MD, DUC THINH PHAM MD, MICHAEL S. KIERNAN MD, MS, MBA, KORY J. LAVINE MD, PhD, JONATHAN D. RICH MD, MANJULA G. ANANTHRAM MBBS, ASHWIN RAVICHANDRAN MD, MPH, ALEXIS E. SHAFII MD, WILLIAM HIESINGER MD, BRENT C. LAMPERT DO, MANDAR A. ARAS MD, PhD, CLAUDIUS MAHR DO, JEFFREY J. TEUTEBERG MD, NADER MOAZAMI MD, Destination Therapy Post-Approval Study Investigators

引用次数: 0

查看原文本刊更多论文

从HVAD批准后研究登记处获得的经验教训：对调查未来VAD技术的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cardiac Failure 医学-心血管系统

CiteScore

7.80

自引率

8.30%

发文量

653

审稿时长

21 days

期刊介绍： Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure - pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.